2-AMINO-1-ETHYL-7-((3R)-3-HYDROXY-4-METHOXY-3-METHYL-1-BUTYN-1-YL)-3-(1H-IMIDAZOL-2-YL)-1,8-NAPHTHYRIDIN-4(1H)-ONE
UNII 338JH2SY4A
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-amino-1-ethyl-7-((3r)-3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-3-(1h-imidazol-2-yl)-1,8-naphthyridin-4(1h)-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 338JH2SY4A.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1412453-70-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H21N5O3 FQPLKTQWEHDNAB-LJQANCHMSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-amino-1-ethyl-7-((3r)-3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-3-(1h-imidazol-2-yl)-1,8-naphthyridin-4(1h)-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.